Intra-Cellular Therapies, Inc. Quarterly Operating Lease, Liability, Noncurrent in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Summary
Intra-Cellular Therapies, Inc. quarterly Operating Lease, Liability, Noncurrent history and growth rate from Q1 2019 to Q2 2024.
  • Intra-Cellular Therapies, Inc. Operating Lease, Liability, Noncurrent for the quarter ending June 30, 2024 was $14.1M, a 2.18% decline year-over-year.
Operating Lease, Liability, Noncurrent, Quarterly (USD)
Operating Lease, Liability, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $14.1M -$315K -2.18% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $12.7M -$2.22M -14.9% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $13.3M -$2.15M -13.9% Dec 31, 2023 10-Q 2024-08-07
Q3 2023 $13.9M -$5.28M -27.5% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $14.4M -$4.64M -24.3% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $15M -$1.8M -10.7% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $15.5M -$3.2M -17.1% Dec 31, 2022 10-K 2024-02-22
Q3 2022 $19.2M -$1.16M -5.69% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $19.1M -$2.61M -12.1% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $16.8M -$5.88M -26% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $18.7M -$4.93M -20.9% Dec 31, 2021 10-K 2023-03-01
Q3 2021 $20.3M -$3.55M -14.9% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $21.7M +$531K +2.51% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $22.6M +$2.92M +14.8% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $23.6M +$3.65M +18.3% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $23.9M +$3.6M +17.8% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $21.2M +$590K +2.87% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $19.7M -$1.14M -5.47% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $20M Dec 31, 2019 10-K 2021-02-25
Q3 2019 $20.3M Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $20.6M Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $20.9M Mar 31, 2019 10-Q 2019-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.